Chemotherapy drugs are known to cause numerous side effects, of which memory loss and heart problems are of great concern. In this study, we are trying to find the effectiveness of 18-week yoga practice on memory loss and heart problems in breast cancer patients who are undergoing chemotherapy.
- Conditions
- Health Condition 1: D249- Benign neoplasm of unspecified breast
- Registration Number
- CTRI/2020/10/028446
- Lead Sponsor
- Central Council for Research in Yoga and Naturopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1)Early-stage II and III breast cancer patients; 2)Scheduled to undergo at least six cycles of chemotherapy; 3)High school education with the ability to read and write English (to perform neuropsychological assessments)
1)Neurological disorders such as any significant head injury, epilepsy, Parkinsonâ??s disease, neurodegenerative disorders, etc. ;2)Uncontrolled diabetes, hypertension, and autoimmune diseases; 3)Patients with prior h/o depression, major psychiatric illness, and Alzheimerâ??s disease and on medication; 4)Brain metastases; 5)Cases with anemia (Hemoglobin < 10gm %); 6)H/o of existing cardiac disease/patients with a cardiac pacemaker; 7)Concurrent medical condition/s likely to influence survival; 8)H/o recent infections or fever in the past two weeks; 9)Regular participation in an active behavioural intervention/yoga in last six months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Role of yoga in evaluating Neuropsychological test assessment and Heart rate variability in breast cancer patients undergoing chemotherapyTimepoint: Two time points 1) Baseline 2) Post 18 weeks
- Secondary Outcome Measures
Name Time Method Echocardiography; Brain-derived Neurotrophic factor; Cortisol; Self reported EORTC QLQ C30; Perceived stress scale; Psychological wellbeingTimepoint: Two time points 1) Baseline 2) Post 18 weeks